Jeffrey Lin
Chief Executive Officer at InstaMed Communications, LLC
Profile
Jeffrey Lin is currently the Chief Executive Officer at InstaMed Communications, LLC since 2023.
He previously worked at Accenture Health & Life Sciences as an Executive.
Mr. Lin completed his undergraduate degree at the University of California, Los Angeles.
Jeffrey Lin active positions
Companies | Position | Start |
---|---|---|
InstaMed Communications, LLC
InstaMed Communications, LLC Miscellaneous Commercial ServicesCommercial Services InstaMed Communications LLC provides healthcare payments network and platform services. The firm’s services include patented estimator with real-time pricing intelligence, patient payments, batch echeck, patient billing, bank bill payments and claims. It also offers member payments, premium payments, claims settlement and transaction gateway. The company was founded by William F. Marvin and Christopher D. Seib in 2004 and is headquartered in Philadelphia, PA. | Chief Executive Officer | 01/11/2023 |
Former positions of Jeffrey Lin
Companies | Position | End |
---|---|---|
Accenture Health & Life Sciences | Corporate Officer/Principal | - |
Training of Jeffrey Lin
University of California, Los Angeles | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
InstaMed Communications, LLC
InstaMed Communications, LLC Miscellaneous Commercial ServicesCommercial Services InstaMed Communications LLC provides healthcare payments network and platform services. The firm’s services include patented estimator with real-time pricing intelligence, patient payments, batch echeck, patient billing, bank bill payments and claims. It also offers member payments, premium payments, claims settlement and transaction gateway. The company was founded by William F. Marvin and Christopher D. Seib in 2004 and is headquartered in Philadelphia, PA. | Commercial Services |
Accenture Health & Life Sciences |
- Stock Market
- Insiders
- Jeffrey Lin